Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...

New research has found that about 2.2 million new diagnoses of type 2 diabetes and 1.2 million new cases of cardiovascular disease were attributed to sugar-sweetened sodas and juices each year.

Traditionally, engineers spent months developing healthcare solutions for clinicians, often missing the mark on practical needs. The Hippocratic AI Agent App Store seeks to turn this paradigm on its ...

Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes.

The convergence of advanced technologies and advancements in drug delivery is reshaping diabetes care. Digital therapeutics ...

Sugar-sweetened beverages were responsible for an estimated 9.8% of new type 2 diabetes cases and 3.1% of cardiovascular ...

Discover how simple dietary changes can prevent diabetes, and meet 'Amma,' the compassionate force behind a free healthcare ...

Innovations in this field are reshaping how medical professionals diagnose, treat, and monitor patients, ultimately leading to improved outcomes and enhanced quality of life. As technology continues ...

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

An educational intervention program enhanced practices related to the safe disposal of sharps used to administer insulin in ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...